HIGHLIGHTS
- who: Ran You from the University of Bologna, Italy have published the research: Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study, in the Journal: (JOURNAL)
- how: The authors conducted a prospective real-world study with a large sample size (including 101 patients with intermediate to advanced HCC) and evaluated the efficacy and safety of camrelizumab plus TACE for treating patients with intermediate to advanced HCC.
SUMMARY
For instance, a study disclosed that a combination of camrelizumab with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.